Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review.

Abstract:

:Urachal cancer is a rare malignancy and the standard treatment is surgical resection. The prognosis of recurrent and metastatic urachal cancer is extremely poor because there is no established chemotherapy regimen. Here, the response of one patient with recurrent urachal cancer to combination chemotherapy of gemcitabine (GEM) and cisplatin (CDDP) (GC) is described. And the chemo- and radiotherapeutic regimens available for such patients are reviewed. A 67-year-old man diagnosed with stage IIIA urachal cancer underwent complete surgical resection. However, pelvic recurrence was detected on computed tomography (CT) 5 months after surgery. GC therapy was started immediately and resulted in a pronounced reduction in pelvic mass after three cycles. However, a follow-up CT scan taken 5 months later showed growth of the pelvic mass and new liver metastasis. He received GC therapy again, which resulted in reduction of the pelvic and liver metastatic masses after two cycles. However, the patient refused another course of GC therapy due to severe side-effects. Subsequent progression of the disease included spread in both regions, followed by death 16 months after recurrence. Various treatment strategies offer relatively long survival of patients with urachal cancer including those with recurrence and metastasis. Although further studies are necessary to determine its therapeutic efficacy, GC therapy may be a useful option in the treatment of urachal tumors, including recurrent tumours.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Miyata Y,Sagara Y,Matsuo T,Ohba K,Takahashi H,Sakai H,Kanetake H

subject

Has Abstract

pub_date

2011-06-01 00:00:00

pages

2335-8

issue

6

eissn

0250-7005

issn

1791-7530

pii

31/6/2335

journal_volume

31

pub_type

杂志文章
  • Molecular Characterization of Second Primary Endometrial Cancer.

    abstract:BACKGROUND/AIM:The objective of this study was to determine the molecular and clinicopathological features, as well as the prognosis of patients with endometrial cancer (EC) having prior malignancy (second primary EC: SPEC) compared with those without a history of prior malignancy (first primary EC: FPEC). MATERIALS A...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.14370

    authors: Haraga J,Nakamura K,Haruma T,Nyuya A,Nagasaka T,Masuyama H

    更新日期:2020-07-01 00:00:00

  • AZD8055 Exerts Antitumor Effects on Colon Cancer Cells by Inhibiting mTOR and Cell-cycle Progression.

    abstract:BACKGROUND/AIM:AZD8055 is an inhibitor of mammalian target of rapamycin (mTOR) that can suppress both mTOR complex 1 (mTORC1) and mTORC2. This study investigated the antitumor effects of AZD8055 on colon cancer. MATERIALS AND METHODS:The effects of AZD8055 on proliferation, apoptosis, and cell cycle of colon cancer ce...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12369

    authors: Chen Y,Lee CH,Tseng BY,Tsai YH,Tsai HW,Yao CL,Tseng SH

    更新日期:2018-03-01 00:00:00

  • Beta-adrenergic influences on doxorubicin-sensitive or -resistant P388 leukemia cells.

    abstract::Taking into account the possible regulatory influences of the beta-adrenergic system on lymphocyte proliferation as well as the proposed role of cyclic 3'-5'-adenosine monophosphate (cAMP) in the modulation of multidrug resistance (MDR) in tumour cells, we have tried to assess the status of the interactions between th...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: D'Amico C,Crescimanno M,Armata MG,Leonardi V,Palazzoadriano M,D'Alessandro N

    更新日期:1992-11-01 00:00:00

  • Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research.

    abstract::Concurrent cisplatin-based chemotherapy and radiotherapy (CCRT) plus brachytherapy is standard treatment for locally advanced cervical cancer. Platinum-based neoadjuvant chemotherapy (NACT) followed by radical hysterectomy has been proposed as an alternative approach, especially for patients with stage Ib2-IIb disease...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.14485

    authors: Gadducci A,Cosio S

    更新日期:2020-09-01 00:00:00

  • Colorectal Kaposi's sarcoma in an HIV-negative male in association with ulcerative rectocolitis: a case report.

    abstract::A rare case and the first reported in Italy of a classic form of colorectal Kaposi's sarcoma, associated with ulcerative rectocolitis, is presented. Following a total proctocolectomy, the patient was disease-free at four years. Some epidemiological risk factors such as sex, age, place of birth and both advanced malari...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Tedesco M,Benevolo M,Frezza F,Mancini R,Carone MD,Mottolese M,Cosimelli M

    更新日期:1999-07-01 00:00:00

  • Vinca alkaloids induce granulocyte-macrophage colony stimulating factor in human peripheral blood mononuclear cells.

    abstract::Several anti-cancer drugs are known to have proliferation-related effects on various cells, such as an activation of some transcription factors and an induction of some cytokines. We examined the effect of anti-cancer drugs on granulocyte-macrophage colony stimulating factor (GM-CSF) induction in human peripheral bloo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ogura K,Ohta S,Ohmori T,Takeuchi H,Hirose T,Horichi N,Okuda K,Ike M,Ozawa T,Siba K,Kasahara K,Sasaki Y,Nakajima H,Adachi M

    更新日期:2000-07-01 00:00:00

  • Monovalent cation transport during the cell cycle (review).

    abstract::This paper reviews the properties and regulation of cation transport during the cell cycle. Extensive modulations occur in both electro-diffusional and non-electro-diffusional cation transport, most prominently during mitosis and G1 phase. These modulations can be related to compositional, structural and dynamic membr...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Boonstra J,Mummery CL,van Zoelen EJ,van der Saag PT,de Laat SW

    更新日期:1982-09-01 00:00:00

  • Uptake of Tc-99m MIBI related to tumour size and type.

    abstract::The accuracy of Tc-99m MIBI scintimammography depends on the uptake in cancer cells being greater than surrounding normal tissue. The aim of this study was to determine which were the dominant factors affecting uptake of Tc-99m MIBI in breast cancer cells in vivo. The tumour to background ratio (TBR) was measured in 7...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Buscombe JR,Cwikla JB,Thakrar DS,Hilson AJ

    更新日期:1997-05-01 00:00:00

  • Correlation of telomerase activity, clinical prognosis and therapy in oral carcinogenesis.

    abstract::Telomerase activity is associated with most malignant tumors. To evaluate the role of telomerase reactivation as a diagnostic and prognostic marker in oral carcinogenesis activity was investigated in mortal and immortal cell lines in eight oral leukoplakias (OL) and 46 oral squamous cell carcinomas (OSCC). Activity wa...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ries JC,Hassfurther E,Steininger H,Kloss FR,Wiltfang J,Girod SC,Neukam FW

    更新日期:2001-03-01 00:00:00

  • Gastric Lavage Malignant Cells (yGL) and Hypohemoglobinemia (yAnemia) as New Systems of Tumor Regression Grading and Prognostic Prediction for Gastric Cancer After Neoadjuvant Treatment.

    abstract:BACKGROUND/AIM:Although reckoned necessary for survival benefit, neoadjuvant chemotherapy (NAC) of gastric cancer (GC) patients has so far provided questionable results. Consequently, searching for new and clearer systems of response to NAC, post-NAC re-evaluation and prognostic prediction appears essential. The purpos...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13208

    authors: Virgilio E,Giarnieri E,Giovagnoli MR,Montagnini M,Proietti A,D'Urso R,Fegiz A,Mercantini P,Balducci G,Cavallini M

    更新日期:2019-02-01 00:00:00

  • Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model.

    abstract:BACKGROUND:Antioxidants have the potential to protect normal tissues against radiation-induced damage, but must not protect tumor cells during radiotherapy. The major objectives were to determine whether a metalloporphyrin antioxidant affects prostate tumor response to radiation and identify possible mechanisms of inte...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gridley DS,Makinde AY,Luo X,Rizvi A,Crapo JD,Dewhirst MW,Moeller BJ,Pearlstein RD,Slater JM

    更新日期:2007-09-01 00:00:00

  • Intermediate stage Hodgkin's disease: preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapy.

    abstract:BACKGROUND:To improve long-term survival by reducing toxicity in intermediate stage Hodgkin's disease patients, we compared the effects of involved field (IF) versus extended field (EF) irradiation administered after four cycles of ABVD regimen. MATERIALS AND METHODS:Two hundred and ten Hodgkin's disease patients, at ...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Anselmo AP,Cavalieri E,Osti FM,Cantonetti M,De Sanctis V,Alfo M,Amadori S,Enrici RM

    更新日期:2004-11-01 00:00:00

  • The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.

    abstract:BACKGROUND:In a previous study we compared the influence of several growth factors on cancer cells in culture and observed that transforming growth factor-beta (TGF-beta) enhanced the invasiveness of several breast cancer cell lines. The objective of the present study was to determine the influence of three unique anti...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Tong GM,Rajah TT,Zang XP,Pento JT

    更新日期:2002-01-01 00:00:00

  • Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma.

    abstract:BACKGROUND:Interleukin-2 (IL-2) and interferon-alpha (IFN-alpha) are the main immuno-biological agents used in the therapy of metastatic renal cell carcinoma (RCC). Unfortunately the promising results obtained in biological studies have not yet been confirmed in clinical studies. One reason is linked to the immunosuppr...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Naglieri E,Lopez M,Lelli G,Morelli F,Amodio A,Di Tonno P,Gebbia N,Di Seri M,Chetri MC,Rizzo P,Abbate I,Casamassima A,Selvaggi FP,Colucci G

    更新日期:2002-09-01 00:00:00

  • Differentially regulated genes in MEN1-transfected BON cells using RT-differential display and oligonucleotide microarrays.

    abstract:BACKGROUND:Apart from inactivation of the MEN1 gene, the molecular mechanisms involved in tumorigenesis of the endocrine organs and MEN1-associated non-endocrine lesions remain unknown. MATERIALS AND METHODS:In order to learn more about down-stream effects upon MEN1 gene inactivation BON1 cells were transfected with a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lopez-Egido JR,Wang Y,Grönberg M,Grimfjärd P,Wang S,Stålberg P,Skogseid B

    更新日期:2009-06-01 00:00:00

  • Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PET.

    abstract::Several studies have reported that high F18-fluorodeoxyglucose (FDG) uptake is predictive of poor prognosis and aggressive features in patients with breast cancer. While these studies evaluated the prognostic value for cases with high FDG uptake, they did not elucidate the meaning of FDG negativity in primary breast c...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fujii T,Yajima R,Tsuboi M,Higuchi T,Obayashi S,Tokiniwa H,Nagaoka R,Takata D,Horiguchi J,Kuwano H

    更新日期:2016-06-01 00:00:00

  • Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.

    abstract:BACKGROUND/AIM:Pancreatic neuroendocrine tumors (pNETs) are rare pancreatic neoplasms, and therapeutic options for pNETs are limited. Metformin is an anti-hypoglycemic drug that appears to have anticancer effects. However, little is known about the effect of metformin on pNETs. In this study, we investigated the anti-p...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13933

    authors: Yamana H,Kato K,Kobara H,Fujihara S,Fujita K,Namima D,Fujita N,Kobayashi K,Kamada H,Morishita A,Tsutsui K,Iwama H,Masaki T

    更新日期:2020-01-01 00:00:00

  • The RING finger protein11 binds to Smad4 and enhances Smad4-dependant TGF-beta signalling.

    abstract:BACKGROUND:In breast carcinomas, prolonged signalling through the TGF-beta receptor promotes latent tumour progression, metastasis and the epithelial-to-mesenchymal transition of tumour cells. Previously, it has been found that the 154 amino acid RING finger protein, RNF11, was overexpressed in high-grade breast tumour...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Azmi PB,Seth AK

    更新日期:2009-06-01 00:00:00

  • An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer.

    abstract:BACKGROUND:Transforming growth factor beta (TGF-beta) plays a complex role in breast carcinogenesis. Initially functioning as a tumor suppressor, this cytokine later contributes to the progression of malignant cells by enhancing their invasive and metastatic potential as well as suppressing antitumor immunity. The purp...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rausch MP,Hahn T,Ramanathapuram L,Bradley-Dunlop D,Mahadevan D,Mercado-Pimentel ME,Runyan RB,Besselsen DG,Zhang X,Cheung HK,Lee WC,Ling LE,Akporiaye ET

    更新日期:2009-06-01 00:00:00

  • All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells.

    abstract::Leukemia inhibitory factor (LIF) is prevalently expressed in human medulloblastomas in vivo and in vitro. Blockage of LIF expression or biological function can inhibit in vitro growth and induce differentiation-like phenotypes of medulloblastoma cells (Med-3), suggesting a redifferentiation potential of Med-3 cells wh...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Liu J,Guo L,Luo Y,Li JW,Li H

    更新日期:2000-07-01 00:00:00

  • Screening of families predisposed to cancer development in The Netherlands.

    abstract::Screening for hereditary tumours provides a basis for secondary prevention. In 1985, the Foundation for the Detection of Hereditary Tumours was established in The Netherlands to coordinate screening in families with hereditary tumours. In the initial period of four years a large number of families were collected. Regi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Vasen HF,Griffioen G,Lips CJ,Struyvenberg A,van Slooten EA

    更新日期:1990-03-01 00:00:00

  • Expression of metastasis associated proteins, CD44v6 and NM23-H1, in pediatric acute lymphoblastic leukemia.

    abstract::Two metastasis-associated proteins, CD44v6 and NM23-H1, are expressed by normal lymphoid cells, the former serving as activation marker and the latter as a constitutive protein. CD44v6 is considered as a marker of poor prognosis of various hematological cancers but its expression was not demonstrated in childhood acut...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Magyarosy E,Sebestyén A,Timár J

    更新日期:2001-01-01 00:00:00

  • Cure of hepatoma in rat with the nitrosourea carmustine (BCNU).

    abstract::Two experiments were performed with a chemically induced hepatoma in the rat. In the first, tumors were inoculated subcutaneously into both flanks. After 10 days, when all rats had tumors, treatment was given intravenously on two successive days with 10 mg carmustine/kg body weight/day. All control rats displayed grow...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Roos G,Stenram U

    更新日期:1994-09-01 00:00:00

  • Association between EGFR-TKI resistance and efficacy of radiotherapy for brain metastases from EGFR-mutant lung adenocarcinoma.

    abstract:AIM:To clarify how patients with epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma with acquired resistance to EGFR-tyrosine kinase inhibitors (TKIs) respond to radiotherapy (RT) for brain metastases. PATIENTS AND METHODS:Forty-seven patients were divided into the following three groups: a TKI-naïve g...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hirata H,Nakamura K,Kunitake N,Shioyama Y,Sasaki T,Ohga S,Nonoshita T,Yoshitake T,Asai K,Inoue K,Nagashima A,Ono M,Honda H

    更新日期:2013-04-01 00:00:00

  • Minireview: DEK and gene regulation, oncogenesis and AIDS.

    abstract::A brief review summarizing the relationships that exist between the DEK protein and gene regulation, oncogenesis and AIDS. ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Sitwala KV,Mor-Vaknin N,Markovitz DM

    更新日期:2003-05-01 00:00:00

  • Influence of tamoxifen on the tumor content of steroid hormone receptors (ER, PgR and AR) in patients with primary breast cancer.

    abstract::A possible influence of tamoxifen (TAM) treatment on the measurable content of some steroid hormone receptors (i.e. ER, PgR, AR) from primary breast cancers has been evaluated. In eleven postmenopausal women, two biopsies were taken from the same tumor, the first biopsy before starting endocrine treatment, and a secon...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lundgren S,Søreide JA,Lea OA

    更新日期:1994-05-01 00:00:00

  • Metastasectomy Improves Survival in Patients with Metastatic Urothelial Carcinoma.

    abstract::Metastatic urothelial carcinoma is one of the most fatal urological malignancies. Cisplatin-based systemic chemotherapy is the standard treatment for metastatic urothelial carcinoma, and there is little evidence to support metastasectomy. The aims of the study were to evaluate the efficacy of metastasectomy and to inv...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11140

    authors: Iwamoto H,Izumi K,Shimura Y,Natsagdorj A,Maolake A,Takezawa Y,Nohara T,Shigehara K,Kadono Y,Mizokami A

    更新日期:2016-10-01 00:00:00

  • Plasminogen activators and steroid receptor concentrations in normal, benign, and malignant breast and ovarian tissues.

    abstract::The plasminogen activator (PA) activity and oestrogen and progestin receptor concentrations were determined in normal, benign and malignant tissues of human breast and ovary. The geometric mean of PA activity was significantly higher (p less than 0.05) in malignant than in normal breast tissue specimens. PA activity w...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Isotalo H,Tryggvason K,Vierikko P,Kauppila A,Vihko R

    更新日期:1983-09-01 00:00:00

  • Treatment of Adrenal Metastases with Conventional or Hypofractionated Image-guided Radiation Therapy - Patterns and Outcomes.

    abstract:BACKGROUND/AIM:Metastases involving the adrenal glands can be treated surgically or with radiation therapy. Retrospective studies indicate that radiotherapy for this indication is safe, well-tolerated and associated with symptom palliation and good local control. We conducted this analysis to report on patterns and out...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12788

    authors: Buergy D,Rabe L,Siebenlist K,Stieler F,Fleckenstein J,Giordano FA,Wenz F,Boda-Heggemann J

    更新日期:2018-08-01 00:00:00

  • Association of copper transporter expression with platinum resistance in epithelial ovarian cancer.

    abstract:BACKGROUND:Copper transporters (CTR) also regulate the cellular transport of platinum drugs, but their role in platinum resistance of ovarian cancer has not been elucidated. MATERIALS AND METHODS:CTR expression in ovarian cancer tissues resected from patients treated by platinum-based chemotherapy was evaluated immuno...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yoshida H,Teramae M,Yamauchi M,Fukuda T,Yasui T,Sumi T,Honda K,Ishiko O

    更新日期:2013-04-01 00:00:00